Ketamine Does Not Alter Brain Reward Processing Five Hours After Infusion
A single-blind crossover trial in healthy volunteers shows racemic ketamine does not alter neural reward processing five hours post-infusion.
A single-blind crossover trial in healthy volunteers shows racemic ketamine does not alter neural reward processing five hours post-infusion.
Researchers at Neuroscience 2026 reported that blood plasma biomarkers can predict individual therapeutic responses to psilocybin and ketamine for depression.
UC San Francisco has launched CANOPY, a federally funded observational study tracking up to 3,000 individuals using psychedelics in real-world ...
A narrative review proposes a context-specific clinical framework to recognize and interpret spreading depolarization in traumatic brain injury and subdural ...
A comprehensive narrative review analyzes clinical trials and developmental pharmacology to evaluate the safety, efficacy, and limitations of opioid-free anesthesia ...
Researchers demonstrated that ketamine induces histone H3 phosphorylation at serine 10 via JNK signaling in hippocampal neurons, while pharmacological JNK ...
A systematic review and meta-analysis of 98 randomized controlled trials found that dexmedetomidine and a combination of midazolam and ketamine ...
A retrospective review of 354 cases in South Africa found that multiple intubation attempts were associated with higher odds of ...
A comprehensive scientific review outlines how ketamine engages diverse neuronal receptors and glial pathways to drive rapid, sustained antidepressant efficacy.
A systematic review and correspondence analyze whether intraoperative ketamine reduces postoperative delirium in older spine and orthopedic surgery patients.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine